These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacogenetics in Child and Adolescent Psychiatry: Background and Evidence-Based Clinical Applications. Malik S; Verma P; Ruaño G; Al Siaghy A; Dilawar A; Bishop JR; Strawn JR; Namerow LB J Child Adolesc Psychopharmacol; 2024 Feb; 34(1):4-20. PubMed ID: 38377525 [TBL] [Abstract][Full Text] [Related]
3. Thoughtful Clinical Use of Pharmacogenetics in Child and Adolescent Psychopharmacology. Ramsey LB; Namerow LB; Bishop JR; Hicks JK; Bousman C; Croarkin PE; Mathews CA; Van Driest SL; Strawn JR J Am Acad Child Adolesc Psychiatry; 2021 Jun; 60(6):660-664. PubMed ID: 32860906 [TBL] [Abstract][Full Text] [Related]
4. Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population. Lee YM; Manzoor BS; Cavallari LH; Nutescu EA Pharmacotherapy; 2018 Feb; 38(2):205-216. PubMed ID: 29286540 [TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetic considerations for late life depression therapy. Pitychoutis PM; Kokras N; Sanoudou D; Dalla C; Papadopoulou-Daifoti Z Expert Opin Drug Metab Toxicol; 2013 Aug; 9(8):989-99. PubMed ID: 23641676 [TBL] [Abstract][Full Text] [Related]
6. Can pharmacogenetics help rescue drugs withdrawn from the market? Shah RR Pharmacogenomics; 2006 Sep; 7(6):889-908. PubMed ID: 16981848 [TBL] [Abstract][Full Text] [Related]
7. The role of depression pharmacogenetic decision support tools in shared decision making. Arandjelovic K; Eyre HA; Lenze E; Singh AB; Berk M; Bousman C J Neural Transm (Vienna); 2019 Jan; 126(1):87-94. PubMed ID: 29082439 [TBL] [Abstract][Full Text] [Related]
8. Commercial Pharmacogenetic Tests in Psychiatry: Do they Facilitate the Implementation of Pharmacogenetic Dosing Guidelines? Fan M; Bousman CA Pharmacopsychiatry; 2020 Jul; 53(4):174-178. PubMed ID: 30900236 [TBL] [Abstract][Full Text] [Related]
10. [Pharmacogenetic study of the response to flecainide and propafenone in patients with atrial fibrillation]. Martínez-Sellés M; Castillo I; Montenegro P; Martín ML; Almendral J; Sanjurjo M Rev Esp Cardiol; 2005 Jun; 58(6):745-8. PubMed ID: 15970126 [TBL] [Abstract][Full Text] [Related]
11. A Critical Evaluation of Pharmacogenetic Information in Package Inserts for Selected Drugs Marketed in India and Its Comparison With US FDA-Approved Package Inserts. Pai SA; Kshirsagar N J Clin Pharmacol; 2016 Oct; 56(10):1232-42. PubMed ID: 26873003 [TBL] [Abstract][Full Text] [Related]
13. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy. Albertini L; Siest G; Jeannesson E; Visvikis-Siest S Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430 [TBL] [Abstract][Full Text] [Related]
14. Clinical and regulatory considerations in pharmacogenetic testing. Schuck RN; Marek E; Rogers H; Pacanowski M Am J Health Syst Pharm; 2016 Dec; 73(23):1999-2006. PubMed ID: 27864207 [TBL] [Abstract][Full Text] [Related]
15. Medication pain management in the elderly: unique and underutilized analgesic treatment options. Atkinson TJ; Fudin J; Pandula A; Mirza M Clin Ther; 2013 Nov; 35(11):1669-89. PubMed ID: 24161287 [TBL] [Abstract][Full Text] [Related]
16. Updates in antiarrhythmic therapy for atrial fibrillation in geriatric patients. Ehrlich C; Tsu LV Consult Pharm; 2015 Feb; 30(2):82-91. PubMed ID: 25695414 [TBL] [Abstract][Full Text] [Related]
17. Gene-drug pairings for antidepressants and antipsychotics: level of evidence and clinical application. Murphy LE; Fonseka TM; Bousman CA; Müller DJ Mol Psychiatry; 2022 Jan; 27(1):593-605. PubMed ID: 34754108 [TBL] [Abstract][Full Text] [Related]